Abstract: Stromal cell-derived factor-1 (SDF-1/ CXCL12) is one of the essential chemokines, which mediates hematopoietic differentiations. However, the mechanism by which SDF-1 expression is regulated in granulocyte differentiation is poorly understood. Here, we suggest a novel mechanism by which all-trans-retinoic acid (ATRA) induces the expression of SDF-1 during the differentiation of promyelomonocytic leukemic U937 cells. Moreover, we also demonstrate that activation of transcription factor C/EBP␤ by ATRA regulates SDF-1 expression in U937 cells. In addition, we show that the cyclin-dependent kinase inhibitors p21 
INTRODUCTION
Chemokines are a group of small (8) (9) (10) (11) (12) (13) (14) , mostly basic, structurally related molecules, which have several conserved cysteine residues. Generally, chemokines regulate leukocyte trafficking and play pivotal roles in the development, homeostasis, and function of the immune system [1, 2] . Despite the fact that chemokines usually bind to multiple receptors and that a chemokine receptor can be engaged by more than one chemokine, ␣-chemokine stromal-derived factor-1 (SDF-1) specifically binds to a specific receptor CXCR4 [3, 4] , suggesting that the SDF-1/CXCR4 engagement plays an important biological role in cellular chemotaxis, angiogenesis, and cell proliferation [5] [6] [7] .
The multistep processes leading to the differentiation of hematopoietic progenitor cells toward the erythroid, lymphoid, or myeloid lineages are regulated, at least in part, by a network of cytokines and various differentiation-inducing agents. Among hematopoietic growth factors, GM-CSF, G-CSF, and M-CSF have been suggested to regulate primary myelopoietic lineage [8, 9] . In addition, GM-CSF and TGF-␤ are able to differentiate human promyelocytic U937 cells into mature myeloid cells. Moreover, synergistic effects were suggested when retinoic acid (RA), vitamin D3, and TNF-␣ were used to stimulate differentiation of U937 cells [10, 11] . Among these, all-trans-RA (ATRA), a vitamin A metabolite, recognized by RA receptor (RAR)/retinoid X receptor (RXR), induces the granulocytic differentiation of U937 cells and contributes to granulopoiesis [12] . ATRA is also known to induce the cyclindependent kinase inhibitor p21 WAF1/CIP1 , resulting in cell cycle arrest at the G 1 /S phase [13] .
In this study, we demonstrated that ATRA induces the expression of SDF-1 regulated by transcription factor C/EBP␤ activation during acute promyelomonocytic leukemic (APL) U937 cell differentiation. These results support that the ATRA-induced differentiation of U937 cells requires C/EBP␤-regulated SDF-1 gene expression. We also determined that a cyclin-dependent kinase inhibitor and differentiation marker, p21 WAF1/CIP1 , is up-regulated by SDF-1␣ in U937 cells and is markedly increased by the costimulation of ATRA and SDF-1␣, resulting in efficient induction of granulocyte differentiation.
MATERIALS AND METHODS
Plasmid construction of SDF-1 promoter and cDNA region A 1.918-kb fragment of SDF-1 5Ј-flanking region was amplified by PCR from normal human spleen genomic DNA (BioChain Institute, Hayward, CA, USA) using the primer set, SDF-1-1918 sense and SDF-1 antisense, with ExTaq Hot Start DNA polymerase (Takara Bio, Japan). A KpnI site was added to the 5Ј end of SDF-1-1918, and a HindIII site was added to the 5Ј end of SDF-1-antisense. The PCR product was cloned into the pGL3 basic luciferase reporter plasmid (Promega, Madison, WI, USA), and the resulting reporter construct was designated pGL3B/SDF-1-1918. Then, five nested 5Ј-end deletion constructs were generated by PCR using the plasmid pGL3B/SDF-1-1918 as the template. Two nested 5Ј-end deletion constructs (pGL3B/SDF-1-546, pGL3B/SDF-1-432) were generated using the restriction enzymes SacI and XmaI. Five constructs generated by PCR were amplified with the same 3Ј-oligonucleotide (SDF-1-antisense) and the corresponding, specific 5Ј-oligonucleotide: SDF- 1-1918  (CCC GGT ACC TCA GGC TTC TGG GAC AGA TCC); SDF-1-1292 (CCC  GGG TAC CCT AAT GCA GCC GCT GAC CG); SDF-1-767 (CCC GGG TAC  CCT CAT TGA ATC TCC CTG CCC A); SDF-1-395 (CCC GGG TAC CTC  AGT TCC CGC CAT CGA AAG G); SDF-1-213 (CCC GGG TAC CCT GAG  AAG GTC AAA GGC CGG AG); SDF-1 antisense (CCC AAG CTT GCG GCT  GAC GGA GAG TGA AAG TG) .
The human (h)SDF-1 cDNA region (1-89 amino acids) was amplified using the primer set SDF-1 cDNA sense (5Ј-CCC GGA ATT CAT GAA CGC CAA GGT CGT-3Ј) and SDF-1 cDNA antisense (5Ј-CCC GCT CGA GCG GTT ACT TGT TTA AAG C-3Ј) from human liver cDNA (BioChain Institute). The PCR product was ligated into the pcDNA expression vector, and the resulting construct was renamed pcDNA/SDF-1.
Cell culture and evaluation of cell differentiation U937 human promyelomonocytic leukemia cells were cultivated in RPMI 1640 with 10% heat-inactivated FBS (Gibco-BRL, Grand Island, NY, USA) and 1% (v/v) penicillin-streptomycin (Gibco-BRL) at 37°C in a humidified atmosphere containing 5% CO 2 and fed every 2 days. Differentiation of U937 cells was evaluated by morphology and nitroblue tetrazolium (NBT) reduction assay and flow cytometry analysis (Beckman Coulter, Fullerton, CA, USA). NBT reduction was measured by adding 1 ml cell suspension (0.5-2ϫ10
6 cells) to a solution containing 2 mg/ml NBT and 20 ng/ml PMA in PBS. The reaction was allowed to proceed for 1 h at 37°C and was stopped by the addition of 0.4 ml cold 2 M HCl. The formazan product was obtained by centrifugation of the sample at 700 g for 10 min. The supernatant was discarded, and the formazan was dissolved in 1 ml Me 2 SO. The absorbance of the solution was measured at 595 nm. Data are expressed as absorbance units/10 6 cells [14] .
Transient transfection and luciferase assay
Cultured cells were transiently transfected by standard electroporation in 24-well culture plates with the SDF-1 luciferase reporter plasmids and the p21 luciferase reporter plasmids and cotransfected with the pSV110/␤-galactosidase reporter plasmid (Promega) and expression vectors for C/EBP␣, C/EBP␤, liver-inhibiting protein (LIP), Creb-binding protein (CBP), p300, RAR␣, RXR, and hyaluronan (HA)/SDF-1. The total amounts of expression vectors were kept constant by adding pcDNA3.1/HisC (Invitrogen, Carlsbad, CA, USA). Relative luciferase activities were measured by Beetle luciferin (Promega) using the multilabel counter VICTOR 3 (Perkin Elmer, Wellesley, MA, USA), and the results were normalized to the ␤-galactosidase activity. All transfection results represent the mean of at least three independent experiments.
RNA isolation and RT-PCR
Total RNA from U937 cells was prepared using Trizol (JBI, Korea), according to the manufacturer's recommendation. The cDNA was synthesized from 5 g total RNA with avian myloblastosis virus RT (Promega) using a random hexamer at 42°C for 1 h. The PCR primers for SDF-1␣ gene amplification were: 5Ј-GCC ATG AAC GCC AAG GTC GT-3Ј (sense), 5Ј-GGC TGT TGT GCT TAC TTG TTT AAA GC-3Ј (antisense); for ␤-actin gene amplification: 5Ј-GAC TAC CTC ATG AAG ATC-3Ј (sense), 5Ј-GAT CCA CAT CTG CTG GAA-3Ј (antisense). The SDF-1␣ cDNAs were amplified by PCR under the following conditions: 38 cycles of denaturation at 95°C for 20 s, annealing at 55°C for 30 s, and extension at 72°C for 30 s in a thermal cycler. The PCR products were examined by electrophoresis on 2% agarose gels.
Chromatin immunoprecipitation (ChIP) assay U937 cells were collected and cross-linked with 1% formaldehyde at 37°C for 10 min and then rinsed with ice-cold PBS twice and centrifuged for 5 min at 2000 g. Cells were then resuspended in 0.2 ml lysis buffer [1% SDS, 10 mM EDTA, 50 mM Tris-Cl, pH 8.1, 1 mM PMSF, protease inhibitor cocktail (Roche, Nutley, NJ, USA)] and sonicated nine times for 10 s each, followed by centrifugation for 10 min. Supernatants were collected and diluted in buffer (1.1% Triton X-100, 0.01% SDS, 1.2 mM EDTA, 167 mM NaCl, 16.7 mM Tris-HCl, pH 8.1) followed by immunoclearing with 60 l protein A-agarose and 2 g sheared salmon sperm DNA for 30 min at 4°C. Immunoprecipitation was performed overnight at 4°C with the C/EBP␤ antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). After immunoprecipitation, 60 l protein A-agarose with 2 g sheared salmon sperm DNA was added, and the incubation was continued for another hour. Precipitates were washed sequentially in the following three washing buffers for 5 min each: a low-salt immune complex washing buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), a high-salt immune complex washing buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, 500 mM NaCl), and a LiCl immune complex washing buffer (0.25 M LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.1). Precipitates were washed two times with Tris-EDTA buffer and then used in PCR assays to determine the binding sequences.
SDS-PAGE and Western blots
Equal amounts of cell lysates from every 1 ϫ 10 6 cell in the presence or absence of ATRA or recombinant hSDF-1 (rhSDF-1) treatment were verified by the Bradford assay and then loaded and separated by SDS-PAGE. The gels were then transferred to polyvinylidene fluoride (PVDF) membranes (Millipore, Bedford, MA, USA). For Western blotting, the membranes were incubated with anti-SDF-1 (R&D Systems, Minneapolis, MN, USA), anti-␤-tubulin, antiPyk2, anti-C/EBP␤, anti-HA, and anti-p21 WAF1/CIP1 (Santa Cruz Biotechnology) in TBST containing 1% nonfat dried skim milk for 2 h at room temperature. After washing three times with cold TBST, the blotted membranes were incubated with peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology) for 30 min at room temperature. After washing three times with cold TBST, the protein bands were visualized using the ECL-Western blotting detection system from Amersham (Arlington Heights, IL, USA).
RNA interference and nucleofection
For small interfering (si)RNA-mediated down-regulation of SDF-1␣, SDF-1␣-specific siRNA and negative control siRNA were purchased from Bioneer (Daejeon, Korea). The siRNA experiments were performed with a final concentration of 700 pmol/L duplex siRNA. For nucleofection into U937 cells, Nucleofector Kit V was used (Amaxa, Gaithersburg, MD, USA). For nucleofection, 2 million low-passage cells were mixed with duplex siRNA directed against SDF-1␣ (target sequence, CUCAUUGAAUCUCCCUGCCCA), and the cell-specific nucleofection program V-01 (Amaxa) was used to deliver the siRNA duplex into the nuclei of the cells. Following nucleofection, cells were incubated for 48 h with ATRA or vehicle (DMSO). Differentiation was subsequently evaluated by the NBT reduction assay.
RESULTS

Expression of SDF-1 and C/EBP␤ is upregulated during ATRA-induced U937 cell differentiation
Although many studies have shown that SDF-1 is expressed in various tissues and cells, such as bone marrow, heart, brain, liver, and hematopoietic cells, it is not clear whether SDF-1 is associated with granulocyte differentiation. To verify the expression of SDF-1 during granulocytic differentiation, we evaluated the expression of SDF-1 by various approaches as described in Materials and Methods. As shown in Figure 1 , A and B, ATRA stimulation in U937 cells increased the levels of SDF-1 mRNA and protein in a time-dependent manner. As shown in Figure 1 , ATRA stimulation increased SDF-1 protein secretion over a 24-h period. In addition, SDF-1 mRNA ex-pression was enhanced in other leukemic cells, such as NB4 and HL60, in response to ATRA (data not shown). These results indicate that ATRA stimulation induces SDF-1 expression during granulocytic differentiation. Previous studies have shown that ATRA is able to induce granulocytic differentiation of U937 cells by inducing p21 WAF1/CIP1 expression [15, 16] . Several studies recently showed that C/EBP␤ can also induce granulocyte differentiation [17, 18] . Moreover, ATRA stimulation has been suggested to up-regulate C/EBP␤ expression, which in turn, enhances its transcriptional activity [19] . By analyzing the DNA sequence of the promoter region of the SDF-1 gene, we found a C/EBP␤-responsive element in the 5Ј-flanking region of the gene. These findings prompted us to examine the protein expression of p21 WAF1/CIP1 and C/EBP␤ in U937 cells stimulated with ATRA. A time-course analysis revealed that ATRA stimulation induced C/EBP␤ and p21 WAF1/CIP1 expression at 6 h after treatment (Fig. 1C) , implying that ATRA stimulation regulates the expression of C/EBP␤ protein as an immediate early response and that C/EBP␤ induction by ATRA could be associated with the SDF-1 expression.
C/EBP␤ regulates SDF-1 promoter activity in ATRA-stimulated U937 cells To address the mechanism by which SDF-1 gene expression is regulated during granulocyte differentiation, we examined the promoter region of the SDF-1 gene. The 5Ј-flanking region of the hSDF-1 gene was obtained by PCR cloning from normal human spleen genomic DNA and cloned into the pGL3 basic luciferase reporter plasmid (Promega). DNA sequencing was performed to confirm the integrity of the sequence. Using the "MOTIF" database analysis program to identify any consensus sequences in the 5Ј-flanking region of the SDF-1 gene, we identified putative binding sites for transcription factors including C/EBPs. We also determined that there is no canonical TATA box in the SDF-1 promoter region, similar to other CXC chemokine promoters [20] .
As ATRA stimulation increased the protein and mRNA levels of SDF-1 ( Fig. 1) , we tested whether ATRA stimulation is able to induce SDF-1 promoter activity. As shown in Figure  2D , ATRA treatment alone increased SDF-1 promoter activity up to 1.8-fold. ATRA is known to bind directly to the ligandbinding domain of RARs, members of the nuclear receptor superfamily [21] [22] [23] , to induce transcriptional activation. Ligand binding also causes the release of corepressor complexes, followed by recruitment of coactivator complexes to the RAR/ RXR dimer, leading to activation of gene transcription [24, 25] . RAR␣ and RAR␥ are believed to be most important in regulating granulopoiesis [26] . Therefore, it is necessary to determine whether the RARs RAR␣ and RXR are involved in transactivation of an ATRA-induced SDF-1 promoter. Therefore, we transiently cotransfected a RAR␣ or RXR expression construct with the SPF-1 promoter reporter construct. Transfection of RAR␣, RXR, or both slightly increased the SDF-1 promoter activity, indicating that RAR␣ or RXR may not mediate SDF-1 expression in response to ATRA in cells (data not shown). However, ectopic expression of C/EBP␤ increased SDF-1 promoter activity significantly. These data suggest that these nuclear receptors do not play a major role in SDF-1 gene expression; rather, ATRA-induced SDF-1 gene expression is mediated largely by the transcription factor C/EBP␤. As shown in Figure 2A , C/EBP␤ dose-dependently increased the luciferase activity derived from the SDF-1 promoter transactivation, and expression of C/EBP␣, another member of the C/EBPs, did not up-regulate SDF-1 expression at the transcriptional level. These results indicate that C/EBP␤ plays a specific role in SDF-1 up-regulation during ATRA-induced granulocyte differentiation.
The coactivator p300 and the homologous CBP appear to enhance transcriptional activity through interactions with a variety of DNA-bound transcription factors, which lead to enhanced activation of the basal transcription machinery [27, 28] . As a previous study showed that C/EBP molecules might also be regulated by CBP and p300 [29] , we next investigated whether C/EBP␤-dependent transactivation of the SDF-1 promoter is mediated by these coactivators. To address this, cells were transiently cotransfected with C/EBP␤ or p300 expression construct and SDF-1 reporter construct. As shown in Figure 2B , these coactivators significantly stimulated transactivation of SDF-1 promoter activity with C/EBP␤ (Fig. 2B) , suggesting that p300 and CBP recruited by C/EBP␤ may induce effective SDF-1 gene transcription in granulocyte differentiation.
The C/EBP␤ RNA transcript, which does not contain the intron found in the gene, is post-transcriptionally regulated by leaky ribosomal scanning, resulting in the expression of four isoforms: the 38-kDa full-length isoform, the 35-kDa liveractivating protein, the 20-kDa LIP, and the 16-kDa truncated isoform [30, 31] (Fig. 2C) . LIP can act as a dominant-negative inhibitor of C/EBP␤ function by forming nonfunctional heterodimers with the other members [30] . Overexpression of LIP inhibited the SDF-1 gene promoter activity transactivated by C/EBP␤ (Fig. 2D) . These data provide more evidence supporting the important transcriptional role of C/EBP␤ in SDF-1 gene expression.
ATRA stimulation causes binding of C/EBP␤ to the SDF-1 promoter region
Next, to identify the C/EBP␤-responsive elements in the SDF-1 promoter region, we generated various deletion mutants of the SDF-1 promoter reporter construct by PCR cloning, as described in Materials and Methods. We cotransfected various deletion mutants of SDF-1 promoter reporter constructs into cells with the C/EBP␤ expression construct and then measured luciferase activity. As shown in Figure 3A , transfection of the -213 SDF-1 promoter reporter construct reduced C/EBP␤-dependent promoter activity significantly (Fig. 3A) . This result indicates that there could be C/EBP␤-responsive elements between residues -395 and -213 within the SDF-1 promoter region. To examine whether the increased SDF-1 promoter activity induced by C/EBP␤ expression results from the direct DNAbinding activity of C/EBP␤ on the SDF-1 promoter, we performed a ChIP assay with C/EBP␤ antibody. Isolated DNA was subjected to PCR before (input) and after ChIP using primer sets designed to amplify the region of the SDF-1 promoter harboring the C/EBP␤-binding site (-395 to -213). The C/EBP␤-binding site in mock-treated, cultured cells appeared to bind C/EBP␤ weakly. However, the SDF-1 promoter and C/EBP␤ complex on chromatin DNA were increased by ATRA stimulation for 48 h in U937 cells (Fig. 3B) . These results indicate that C/EBP␤ transactivates SDF-1 gene expression at the transcriptional level by directly binding to the promoter region of SDF-1 gene during ATRA-induced granulocyte differentiation.
SDF-1 stimulation promotes p21 WAF1/CIP1 and Pyk expression in U937 cells
Transcriptional control of p21 WAF1/CIP1 by p53-dependent and -independent mechanisms is critical for growth arrest and differentiation of various tumors [32, 33] . In addition, p21 WAF1/ CIP1 is known as a target gene for ATRA in normal haematopoiesis [34] . To determine whether SDF-1 stimulation can regulate p21 WAF1/CIP1 expression, cells were cotransfected with the p21 WAF1/CIP1 promoter as a reporter and the HAtagged SDF-1 expression plasmid. Ectopic expression of SDF-1 dose-dependently increased the p21 WAF1/CIP1 promoter activity (see Fig. 5A ). The transfection efficiency and protein expression of HA-tagged SDF-1 were confirmed by Western blots using anti-HA antibody (Fig. 4A, lower) . Likewise, p21 WAF1/CIP1 mRNA levels were strongly induced by 40 ng/ml rSDF-1␣ after 48 h treatment in U937 cells. We also observed that SDF-1 stimulation increased mRNA expression of another cyclin-cyclin-dependent kinase inhibitor, p27 KIP1 (Fig. 4B) . We next tested whether SDF-1 could regulate the expression of p21 WAF1/CIP1 protein in U937 cells. To study this, the expression of p21 WAF1/CIP1 and Pyk genes was evaluated in ATRA-induced granulocyte differentiation. Protein lysates were prepared from differentiating U937 cells followed by SDS-PAGE analysis. Western blotting was performed with antibodies against Pyk and p21
. As shown in Figure  5C , p21 WAF1/CIP1 protein expression was low in mock-treated U937 cells, but its expression was up-regulated gradually by SDF-1 in a dose-and time-dependent manner (Fig. 4, C and  D) . In addition, Pyk2 was induced by rSDF-1 and might play a role in activating Pyk2-mediated signaling pathways, including adhesion molecules, during U937 cell differentiation (Fig.  4, C and D) . Therefore, these results indicate that SDF-1 may play an important role in U937 cell differentiation through induction of differentiation-related gene expression including p21 WAF1/CIP1 , p27, and Pyk.
SDF-1 and ATRA synergistically up-regulate p21 WAF1/CIP1 expression and induce U937 cell differentiation
We then studied whether ATRA and SDF-1 cooperate to induce p21 protein expression. As expected, the results showed that p21 WAF1/CIP1 protein levels were up-regulated by cotreatment with ATRA and rSDF-1 (Fig. 5A) . Also, treatment with ATRA and rSDF-1 increased Pyk2 and C/EBP␤ protein levels significantly. Next, we investigated the costimulatory effect of ATRA (10 Ϫ6 or 10 Ϫ7 M) and rSDF-1(10 ng/ml) in U937 cells. As shown as Figure 5B , cotreatment with ATRA and SDF-1 synergistically induced granulocyte differentiation as measured by the NBT reduction assay. It is interesting that our data showed that the cotreatment with 10 Ϫ6 M ATRA and rSDF-1 increased the protein expression of p21 WAF1/CIP1 and Pyk2 more effectively than 10 Ϫ6 M ATRA alone. These data indicate that ATRA signaling and SDF-1 production are sufficient to induce granulocyte differentiation through up-regulation of target gene expression.
Furthermore, to confirm the functional relevance of ATRAinduced SDF-1 in U937 cell differentiation, we performed SDF-1 knockdown studies using SDF-1 siRNA in ATRA- induced granulocyte differentiation of U937 cells. As shown in Figure 5C , SDF-1 siRNA inhibited ATRA-induced granulocyte differentiation significantly, as measured by NBT reduction. This result provides direct evidence that SDF-1 expression plays an important role in granulocyte differentiation.
DISCUSSION
In this study, we demonstrated that ATRA stimulation elevated SDF-1 expression in granulocytic differentiation (Fig. 1) . Also, to investigate the mechanism by which SDF-1 gene expression is regulated, the promoter region of the SDF-1 gene was examined, and transient transfection with various deletion mutants and ChIP assays revealed that the transcription factor C/EBP␤ binds to the promoter region of the SDF-1 gene to up-regulate its expression in response to ATRA.
Although little is known about the ATRA target genes that regulate granulocyte differentiation, p21 WAF1/CIP1 and p27 cyclin-dependent kinase inhibitors have been shown to be involved in granulocyte differentiation. Ectopic expression of p21 WAF1/CIP1 and p27 in a human myeloblastic leukemia cell line resulted in the induction of granulocyte differentiation. Moreover, several inducers of myeloid cell differentiation upregulate p21 WAF1/CIP1 expression [35] . Therefore, the p21 WAF1/ CIP1 promoter appears to harbor multiple response elements for several differentiation signals, such as ATRA-mediated growth arrest and the subsequent differentiation, followed by G 1 arrest in the cell cycle. We showed that the p21 WAF1/CIP1 expression level was up-regulated during granulocyte differentiation of U937 cells. Ectopic expression of C/EBP␤ also resulted in enhanced expression of p21 WAF1/CIP1 , whereas p21
expression is reduced in cells transfected with dominant-negative C/EBP␤ (data not shown). This suggests that transcriptional activation of p21 WAF1/CIP1 is involved in C/EBP␤-dependent granulocyte differentiation, by inducing cell cycle arrest, which might be necessary for the induction of terminal differentiation. Hematopoietic cell development is controlled by lineagespecific and nonspecific transcription factors [36, 37] . C/EBPs belong to the basic region/leucine zipper class of transcription factors and play a role in the differentiation of a broad range of tissues. In the hematopoietic system, C/EBP family members are expressed mostly in the macrophage and granulocytic lineage and participate in the regulation of macrophage and granulocyte-restricted genes, such as the M-CSF receptor, G-CSF receptor, and GM-CSF receptor genes [12, 38] . Targeted disruption of the C/EBP␦, C/EBP␤, or C/EBPε gene resulted in defects, which predominantly affected the granulocytic lineage [39] . Recently, C/EBP␤ was shown to be enhanced and required in ATRA-induced differentiation of APL cells. Moreover, inhibiting C/EBP activity, specifically C/EBP␤ expression, dramatically reduced the APL response to ATRA [19] .
Since the successful introduction of ATRA for treatment of APL, a potentially less-toxic cancer therapeutic strategy known as "differentiation therapy" has been developed to induce cancer cells to undergo terminal differentiation of cancer cells to block their continuous proliferation. Therefore, understanding the mechanisms by which ATRA induces leukemia cell differentiation has attracted significant attention. Despite the success of ATRA in the treatment of APL, many patients relapse with ATRA-resistant disease. Initially, the possibility of using ATRA and SDF-1 in a combination treatment was investigated in vitro. ATRA and SDF-1 were found to increase p21 WAF1/CIP1 expression synergistically and induce differentiation when used in combination (Fig. 5) .
Based on the data presented in this study, these results can be interpreted in the context of a model of ATRA-induced leukemic cell differentiation mediated by SDF-1. This model is consistent with the finding that strongly suggests that the mechanism involves SDF-1 in leukemic cell differentiation [40 -43] . Thus, in addition to demonstrating the novel relationship between ATRA and SDF-1, this work provides an example of the physiological relevance of the differentiationinducing agent and the chemokine cross-talk within each signaling pathway. Ϫ7 or 10 Ϫ6 M ATRA concurrently as indicated. Whole cell lysate from each sample was separated on 12% SDS-PAGE and transferred to PVDF membranes, which were subjected to Western blot analysis using antibodies specific for p21, Pyk2, and C/EBP␤ as indicated. Western blot detection of ␤-tubulin was used to estimate protein loading for each lane. Data shown are representative of three independent experiments. (B) U937 cells were treated with ATRA and rSDF-1 for 48 h, and the differentiation yield was determined by scoring NBT reduction; the absorbance values are presented. Data shown are representative of three independent experiments. Values represent mean Ϯ SD (nϭ3-4); *, P Ͻ 0.1; **, P Ͻ 0.05, compared with mock transfectants. (C) For siRNA-mediated down-regulation of SDF-1␣, negative control siRNA or SDF-1␣-specific siRNA was electroporated into U937 cells with Nucleofector Kit V (Amaxa); cells were then incubated with ATRA or vehicle (DMSO) for 48 h. (Left) Differentiation was evaluated by NBT reduction assay. Values represent mean Ϯ SD (nϭ3); *, P Ͻ 0.005, compared with mock transfectants. (Right) Total RNA was prepared and analyzed for SDF-1␣ and p21 expression by RT-PCR as described. Actin was used as an internal control. The decreased protein expression of SDF-1␣ with specific siRNA for SDF-1␣ in the transfecton of pcDNA3/GST/SDF-1␣ was confirmed with Western blot analysis using anti-GST antibody.
